ASHLEY FLEMING: Open Payments
NPI 1205274651 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 33 payments from 14 companies in 2025. Trend: 2023 $271 · 2024 $20 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $190 |
| PFIZER INC. | 12 | $175 |
| AstraZeneca Pharmaceuticals LP | 2 | $140 |
| Sumitomo Pharma America, Inc. | 1 | $130 |
| Lilly USA, LLC | 1 | $99 |
| Novo Nordisk Inc | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Rhythm Pharmaceuticals, Inc. | 1 | $24 |
Products named: AIRSUPRA, GEMTESA, General - Angioplasty, ELIQUIS, ZEPBOUND, Wegovy, General - Thrombectomy, ZAVZPRET.
Industry payments across FL — which companies pay providers there.
